Below are Views on Nureca listing update By Mr. Yash Gupta - Angel Broking Ltd
Nureca debuted with a very good listing gain of 59%, we recommend investors who applied for listing can book profit in the next 1-2 days and short term to hold stock. Even at these valuations stock looks attractive for long term.
Nureca limited is a B2C company engaged in the business of home healthcare and wellness products. The company enables their customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle.
Nureca is a digital first company wherein they sell their products through online channel partners such as e-commerce players, distributors and retailer. Further, they also sell their products through their own website
Nureca classifies their products portfolio under the 5 categories such as Chronic Device Products, Orthopedic Products, Mother and Child Products, Nutrition Supplements and Lifestyle Products.
Above views are of the author and not of the website kindly read disclaimer